Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells.
Anthracycline daunorubicin (DNR) is one of the major antitumor agents widely used in the treatment of myeloid leukemia. Unfortunately, the clinical efficacy of DNR was limited because of its cytotoxity at high dosage. As a novel cytoprotective mechanism for tumor cell to survive under unfavorable co...
Main Authors: | Weidong Han, Jie Sun, Lifeng Feng, KaiFeng Wang, Da Li, Qin Pan, Yan Chen, Wei Jin, Xian Wang, Hongming Pan, Hongchuan Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3229606?pdf=render |
Similar Items
-
Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells.
by: Huey-Lan Huang, et al.
Published: (2011-01-01) -
Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo
by: Bao-an Chen, et al.
Published: (2009-09-01) -
Potential of Bacillus subtilis lipopeptides in anti-cancer I: induction of apoptosis and paraptosis and inhibition of autophagy in K562 cells
by: Haobin Zhao, et al.
Published: (2018-05-01) -
20(S)-Ginsenoside Rh2 Induce the Apoptosis and Autophagy in U937 and K562 Cells
by: Jianjian Zhuang, et al.
Published: (2018-03-01) -
Involvement of miR-125a in resistance to daunorubicin by inhibiting apoptosis in leukemia cell lines
by: Haitao Bai, et al.
Published: (2017-04-01)